Market Cycle Dynamics (MCD) was created to research and track global market cycles in price, time and sentiment, and publish The International Market Cycle Dynamics Letter and the Interim Briefing. The Market Cycle Dynamics (MCD) approach and method of market cycle analysis provides a “formula timing plan”. The goal is to provide market cycle turning point analysis for individual and professional investors and traders who make their own informed investment decisions.
David Knox Barker is the founder of Market Cycle Dynamics, LLC, and the publisher and editor of The International Market Cycle Dynamics Letter. Barker is one of the world’s foremost experts on market cycles, the economic long wave of innovation, and Fibonacci based market analysis. He is author of The K Wave (1995, Dow Jones Erwin), and a 2012 eBook, also published as Jubilee on Wall Street (1987, 2009). He is currently working on a 5th edition with the working title of Market Cycle Dynamics; The New Science of Cycles. He is a writer, entrepreneur and technical market analyst. He has researched stock market cycles and written on the impact of the long wave on international financial markets and the international political economy for over 40 years. Barker developed the powerful Market Cycle Dynamics Formula Timing Plan approach to market cycle analysis based on decades of market cycle research in price, time and sentiment. Barker also discovered a unique Fibonacci grid drill-down method that works in any market to uncover multiple levels of nested Fibonacci grids within grids for identification of cycle pivot points in long and short cycles. Barker last spoke publicly on the K Wave was in 2013 to the Computerized Special Interest Group that meets at MIT. Barker continues writing and publishing the letter, since he thoroughly enjoys it. He believes there is important undiscovered science in the cycles of human activity related to market cycles as “fields” of human action.
Barker’s primary occupation is in healthcare. He has been a healthcare entrepreneur for over 30 years. He was founder and CEO for ten years from 1997 to 2007 of a successful life sciences research and marketing services company, serving a majority of the top 20 global life science companies that was sold to a public company in 2014. Barker now serves as CEO and is founder of ALP Life Sciences, Inc. ALP is a nutritional medicine and lipid metabolism research company, developing the ALP Protocol for managing and optimizing the Omega 3 Index (O3i) to manage lipid disorders. Barker has long viewed nutritional medicine as one of the industries that will flourish in the new K Wave that began in 2020. The ALP name derives from the emerging science of Applied Lipid Polymorphism (ALP). The ALP omega 3 science and the Lipoveson(TM) project is targeting inflammatory chronic disease in general and the global epidemic of fatty liver disease in the form of metabolic dysfunction-associated steatotic liver diseases (MASLD) and its advanced stage of metabolic dysfunction associated steatohepatitis (MASH) in particular. ALP is the manufacturer and distributor of ALP High 3, a highly concentrated, pure and bio available formulation of Omega 3 fish oil available, with 10X and greater absorption over typical products.
Barker received his bachelor’s degree with a major in finance and a master’s degree in political science, with a focus on international political economy. His master’s thesis research explored disequilibrium in the international political economy from the long wave perspective. Barker lives in the beautiful Blue Ridge mountains of North Carolina, and in the Alps of Switzerland. His hobbies, in addition to market cycle analysis, include reading, writing, hiking in the Blue Ridge Mountains and in the Alps, and discussing big ideas with family and friends.
MCD is a market cycle dynamics analysis service and does not provide investment advice. MCD is not a registered investment advisor with the SEC. Investing and trading involves risk that should be explained to you by your investment advisor.
